vs

Side-by-side financial comparison of Chime Financial, Inc. (CHYM) and UiPath, Inc. (PATH). Click either name above to swap in a different company.

Chime Financial, Inc. is the larger business by last-quarter revenue ($543.5M vs $411.1M, roughly 1.3× UiPath, Inc.). UiPath, Inc. runs the higher net margin — 48.4% vs -10.1%, a 58.4% gap on every dollar of revenue. On growth, Chime Financial, Inc. posted the faster year-over-year revenue change (28.8% vs 15.9%). UiPath, Inc. produced more free cash flow last quarter ($25.1M vs $15.4M).

Chime Financial, Inc. is an American financial technology company based in San Francisco, California. It provides fee-free mobile banking services through two national banks, Stride Bank and The Bancorp Bank.

UiPath Inc. is a global software company that develops artificial intelligence (AI) and agentic automation and orchestration software. The company's software enables the building and orchestration of AI agents to automate complex processes and workflows.

CHYM vs PATH — Head-to-Head

Bigger by revenue
CHYM
CHYM
1.3× larger
CHYM
$543.5M
$411.1M
PATH
Growing faster (revenue YoY)
CHYM
CHYM
+12.9% gap
CHYM
28.8%
15.9%
PATH
Higher net margin
PATH
PATH
58.4% more per $
PATH
48.4%
-10.1%
CHYM
More free cash flow
PATH
PATH
$9.7M more FCF
PATH
$25.1M
$15.4M
CHYM

Income Statement — Q3 FY2025 vs Q3 FY2026

Metric
CHYM
CHYM
PATH
PATH
Revenue
$543.5M
$411.1M
Net Profit
$-54.7M
$198.8M
Gross Margin
87.2%
83.3%
Operating Margin
-11.9%
3.2%
Net Margin
-10.1%
48.4%
Revenue YoY
28.8%
15.9%
Net Profit YoY
-148.4%
1966.2%
EPS (diluted)
$-0.15
$0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHYM
CHYM
PATH
PATH
Q4 25
$411.1M
Q3 25
$543.5M
$361.7M
Q2 25
$528.1M
$356.6M
Q1 25
$423.6M
Q4 24
$354.7M
Q3 24
$421.9M
$316.3M
Q2 24
$384.2M
$335.1M
Q1 24
$405.3M
Net Profit
CHYM
CHYM
PATH
PATH
Q4 25
$198.8M
Q3 25
$-54.7M
$1.6M
Q2 25
$-923.4M
$-22.6M
Q1 25
$51.8M
Q4 24
$-10.7M
Q3 24
$-22.0M
$-86.1M
Q2 24
$385.0K
$-28.7M
Q1 24
$33.9M
Gross Margin
CHYM
CHYM
PATH
PATH
Q4 25
83.3%
Q3 25
87.2%
82.2%
Q2 25
87.3%
82.1%
Q1 25
84.8%
Q4 24
82.0%
Q3 24
87.3%
80.0%
Q2 24
86.9%
83.5%
Q1 24
86.8%
Operating Margin
CHYM
CHYM
PATH
PATH
Q4 25
3.2%
Q3 25
-11.9%
-5.6%
Q2 25
-176.2%
-4.6%
Q1 25
7.9%
Q4 24
-12.2%
Q3 24
-7.3%
-32.7%
Q2 24
-2.5%
-14.8%
Q1 24
3.7%
Net Margin
CHYM
CHYM
PATH
PATH
Q4 25
48.4%
Q3 25
-10.1%
0.4%
Q2 25
-174.8%
-6.3%
Q1 25
12.2%
Q4 24
-3.0%
Q3 24
-5.2%
-27.2%
Q2 24
0.1%
-8.6%
Q1 24
8.4%
EPS (diluted)
CHYM
CHYM
PATH
PATH
Q4 25
$0.37
Q3 25
$-0.15
$0.00
Q2 25
$-7.29
$-0.04
Q1 25
$0.09
Q4 24
$-0.02
Q3 24
$-0.34
$-0.15
Q2 24
$0.00
$-0.05
Q1 24
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHYM
CHYM
PATH
PATH
Cash + ST InvestmentsLiquidity on hand
$445.0M
$1.4B
Total DebtLower is stronger
Stockholders' EquityBook value
$1.4B
$1.9B
Total Assets
$2.0B
$2.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHYM
CHYM
PATH
PATH
Q4 25
$1.4B
Q3 25
$445.0M
$1.4B
Q2 25
$868.3M
$1.6B
Q1 25
$1.6B
Q4 24
$1.6B
Q3 24
$270.8M
$1.7B
Q2 24
$295.4M
$1.9B
Q1 24
$1.9B
Stockholders' Equity
CHYM
CHYM
PATH
PATH
Q4 25
$1.9B
Q3 25
$1.4B
$1.7B
Q2 25
$1.4B
$1.7B
Q1 25
$1.8B
Q4 24
$1.7B
Q3 24
$-1.9B
$1.8B
Q2 24
$-1.9B
$2.0B
Q1 24
$2.0B
Total Assets
CHYM
CHYM
PATH
PATH
Q4 25
$2.9B
Q3 25
$2.0B
$2.6B
Q2 25
$1.9B
$2.6B
Q1 25
$2.9B
Q4 24
$2.7B
Q3 24
$2.7B
Q2 24
$2.8B
Q1 24
$3.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHYM
CHYM
PATH
PATH
Operating Cash FlowLast quarter
$17.5M
$28.3M
Free Cash FlowOCF − Capex
$15.4M
$25.1M
FCF MarginFCF / Revenue
2.8%
6.1%
Capex IntensityCapex / Revenue
0.4%
0.8%
Cash ConversionOCF / Net Profit
0.14×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHYM
CHYM
PATH
PATH
Q4 25
$28.3M
Q3 25
$17.5M
$41.6M
Q2 25
$2.7M
$119.0M
Q1 25
$146.1M
Q4 24
$28.1M
Q3 24
$46.4M
Q2 24
$100.0M
Q1 24
$145.6M
Free Cash Flow
CHYM
CHYM
PATH
PATH
Q4 25
$25.1M
Q3 25
$15.4M
Q2 25
$-888.0K
$106.2M
Q1 25
$138.7M
Q4 24
$23.2M
Q3 24
$45.0M
Q2 24
$98.8M
Q1 24
$141.8M
FCF Margin
CHYM
CHYM
PATH
PATH
Q4 25
6.1%
Q3 25
2.8%
Q2 25
-0.2%
29.8%
Q1 25
32.7%
Q4 24
6.5%
Q3 24
14.2%
Q2 24
29.5%
Q1 24
35.0%
Capex Intensity
CHYM
CHYM
PATH
PATH
Q4 25
0.8%
Q3 25
0.4%
0.0%
Q2 25
0.7%
3.6%
Q1 25
1.7%
Q4 24
1.4%
Q3 24
0.4%
Q2 24
0.4%
Q1 24
0.9%
Cash Conversion
CHYM
CHYM
PATH
PATH
Q4 25
0.14×
Q3 25
26.25×
Q2 25
Q1 25
2.82×
Q4 24
Q3 24
Q2 24
Q1 24
4.29×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHYM
CHYM

Payments Revenue$363.2M67%
Platform Related Revenue$180.4M33%

PATH
PATH

Subscription Services$247.6M60%
License$150.0M36%
Professional Services And Other$13.5M3%

Related Comparisons